Monograph

D07AC13 - Mometasone

Not porphyrinogenic

Rationale

Several references stating non-porphyrinogenicity of glucocorticoids.

Chemical description

Strong glucocorticoid, creme/salve 0.1%, cutaneous solution 0.1%. Used in psoriasis and other steroide sensitive dermatoses. Risk for systemic exposure in application on large areas of the skin. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncanâ€™s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.

IPNet drug reports

Uneventful use reported in 5 patients with acute porphyria.

Similar drugs

Explore alternative drugs in similar therapeutic classes D07A / D07AC or go back.

References

Tradenames

Show more details and information about the listed tradenames

Mometasonfuroaat · Monovo

Elocom · Elocom Onguent

Elocom · Konex · Mometasona · Monovo

Elocom · Mofuder · Momegen

Mundoson · Ovison · Ovixan

Elocom · Mometazona

Elocom · Monovo · Ovixan

Elocon · Mometasone · Mometasone 0.1% ointment 10% in White soft paraffin · Mometasone 0.1% ointment 25% in White soft paraffin · Mometasone 0.1% ointment 50% in White soft paraffin